£63.94

CRC Press Quantitative Drug Design: A Critical Introduction, Second Edition

Price data checked 5 days ago

View at Amazon

Price History & Forecast

Last 86 days • 86 data points (No recent data available)

Historical
Generating forecast...
£63.94 £58.36 £59.58 £60.80 £62.01 £63.23 £64.45 23 January 2026 13 February 2026 06 March 2026 27 March 2026 18 April 2026

Price Distribution

Price distribution over 86 days • 2 price levels

Days at Price
Current Price
39 days 47 days · current 0 12 24 35 47 £59 £64 Days at Price

Price Analysis

Most common price: £64 (47 days, 54.7%)

Price range: £59 - £64

Price levels: 2 different prices over 86 days

Description

Product Description Since the publication of the first edition, the field has changed dramatically. Scientists can now explicitly consider 3D features in quantitative structure-activity relationship (QSAR) studies and often have the 3D structure of the macromolecular target to guide the 3D QSAR. Improvements in computer hardware and software have also made the methods more accessible to scientists. Taking these developments into account, Quantitative Drug Design: A Critical Introduction, Second Edition shows scientists how to apply QSAR techniques at a state-of-the-art level. New to the Second Edition A new chapter on methods that identify the 3D conformations to use for 3D QSAR New discussions on partial least squares, multidimensional scaling, clustering, support vector machines, kNN potency prediction, and recursive partitioning Expanded case studies that include the results of data that has been re-analyzed using newer methods A new case study on the discovery of novel dopaminergics with pharmacophore mapping and CoMFA A new case study on the application of CoMFA to series in which the 3D structure of the ligand-protein complex is known Based on the author’s four decades of experience in all areas of ligand-based computer-assisted drug design, this invaluable book describes how to transform ligand structure-activity relationships into models that predict the potency or activity/inactivity of new molecules. It will help you avoid traps when dealing with quantitative drug design. About the Author For more than forty years, Yvonne Connelly Martin worked in drug research at Abbott Laboratories. A long-time leader in computer-assisted drug design, she was a recipient of the Herman Skolnik award of the American Chemical Society in 2009 and the accomplishment award of the Society for Biomolecular Sciences in 2005. Dr. Martin is currently a member of the editorial advisory board and Perspectives editor of the Journal of Computer-Aided Molecular Design.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
27 September 2019
Listed Since
25 June 2019

Barcode

No barcode data available